Trial Profile

CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction

Status: Not yet recruiting

Phase of Trial: Phase III

Latest Information Update: 12 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Belatacept (Primary) ; Tacrolimus
Indications Renal transplant rejection
Focus Therapeutic Use
Acronyms TRANSIBELA

Most Recent Events

30 Mar 2020 Planned initiation date changed from 4 Jan 2020 to 1 Sep 2020.
25 Nov 2019 Planned initiation date changed from 9 Jul 2019 to 4 Jan 2020.
11 Jul 2019 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com